CD49d shows superior performance characteristics for flow cytometric prognostic testing in chronic lymphocytic leukemia/small lymphocytic lymphoma

Publisher： John Wiley & Sons Inc

E-ISSN： 1552-4957|94|1|129-135

ISSN： 1552-4949

Source： Cytometry. Part B: Clinical Cytometry, Vol.94, Iss.1, 2018-01, pp. : 129-135

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Composite mantle cell lymphoma and chronic lymphocytic leukemia/small lymphocytic lymphoma

By  

Cytometry. Part B: Clinical Cytometry, Vol. 94, Iss. 1, 2018-01 ,pp. : 148-150

John Wiley & Sons Inc

Access to resources Recommend Favorite

Detection of Trisomy 12 by Fluorescence in Situ Hybridization on Archival Cytopathologic Material in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

By  

Acta Cytologica, Vol. 44, Iss. 3, 2011-04 ,pp. : 368-374

Karger

Access to resources Recommend Favorite

Aberrant NK cell associated marker (CD56 and CD57) expression in chronic lymphocytic leukemia

By  

Cytometry. Part B: Clinical Cytometry, Vol. 88, Iss. 5, 2015-09 ,pp. : 348-351

John Wiley & Sons Inc

Access to resources Recommend Favorite

CD40-ligand/interleukin-2 vaccines in chronic lymphocytic leukemia: the impact of vaccine design

By Rezvani Katayoun  

Cytotherapy, Vol. 13, Iss. 9, 2011-10 ,pp. : 1029-1030

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Comparison of two CD40-ligand/interleukin-2 vaccines in patients with chronic lymphocytic leukemia

By Okur Fatma Visal   Yvon Eric   Biagi Ettore   Dotti Gianpietro   Carrum George   Heslop Helen   Mims Martha P.   Fratantoni Joseph C.   Peshwa Madhusudan V.   Li Linhong   Brenner Malcolm K.  

Cytotherapy, Vol. 13, Iss. 9, 2011-10 ,pp. : 1128-1139

Ashgate Publishing Ltd

Access to resources Recommend Favorite